Testicular Cancer Biomarker Detection Service
Testicular cancer is a malignant tumor that affects the health of young men. The use of biomarkers has brought new research prospects to its early diagnosis and disease treatment. As an expert in the field of biomarkers, Creative BioMart Biomarker has extensive experience in detecting various tumor-related biomarkers and can provide customers with fast and accurate test results. We provide customers with high-quality testicular cancer biomarker detection services to meet customer research needs and help customers shorten the research cycle.
Testicular Cancer
Testicular cancer is a common malignant tumor in young men aged 15-34 years, and it accounts for 1.5% and 5% of male tumors and urinary system tumors, respectively. The testis is an important part of the male reproductive system. It is the place where androgens (such as testosterone) and sperm cells are made. Testicular cancer is almost always malignant. Testicular germ cell tumors are the most common type of testicular cancer, accounting for 90-95%. For example, seminoma, embryonal carcinoma, and teratoma are common testicular germ cell tumors. Non-germ cell tumors account for 5% to 10% of testicular tumors, including lymphoid and hematopoietic tumors, sex cord and gonadal stromal tumors, and metastatic tumors of other primary tumors. Similar to some tumors, testicular germ cell tumors have significant tumor heterogeneity due to their special histological characteristics. Most testicular germ cell tumors contain more than one histological feature and are therefore called mixed germ cell tumors. The heterogeneity of tumors brings difficulties to the treatment and research of tumors, and the introduction of biomarkers can bring new opportunities for early diagnosis, prognosis analysis, disease risk assessment, disease course monitoring and pharmacodynamic analysis of tumors. For testicular cancer, circulating biomarkers can help clinicians understand the natural history of the disease, which can help clinical management, treatment decision-making, disease stage and prognosis analysis of patients with testicular cancer. Although there are some common biomarkers for malignant tumors that can be used in the study of testicular cancer and have a huge impact on the diagnosis and treatment of testicular cancer, there is still a need to find biomarkers that are specific and sensitive to testicular cancer.
Figure 1. Schematic representation of the types of testicular germ cell tumours (Cheng, et al. 2018)
Our Advantages
- Guarantee high accuracy and sensitivity for single biomarker detection
- Ensure high repeatability of single biomarker detection
- Short turn-around time of detection service
- Competitive price in the market of detection services
- Provide multiple detection methods
- Accept a wide range of sample types
Our Single Biomarker Detection Services Related to Testicular Cancer (including but not limited to the following):
- HE-4 Detection Service
- AFP Detection Service
- HCG Detection Service
- LDH Detection Service
- PLAP Detection Service
- TRA-1-60 Detection Service
- NSE Detection Service
- CRP Detection Service
Workflow of Single Biomarker Detection at Creative BioMart Biomarker
Creative BioMart Biomarker provides high-quality detection services for testicular cancer biomarkers that are applicable to a variety of biomarkers. If you do not find detection services for your research object on this webpage, you can find more biomarkers in biomarker menu or contact us to get more help. We have a technical team with rich experience in tumor biomarker detection, as well as multiple technical platforms suitable for biomarker detection, capable of accurate, specific and sensitive detection for various types of samples. If you are seeking pancreatic cancer biomarker detection services, please feel free to contact us, we look forward to being your trusted partner.
References:
- Leão, R.; et al. Testicular cancer biomarkers: a role for precision medicine in testicular cancer. Clinical Genitourinary Cancer. 2019, 17(1): e176-e183.
- Cheng, L.; et al. Testicular cancer. Nature Reviews Disease Primers. 2018, 4: 29.
